Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of inhaled levodopa in Parkinson's disease
NL-OMON22984Not yet recruiting
- Sponsor
- Department of Pharmaceutical Technology and Biopharmacy
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of levodopa in Parkinson's disease (PD) (2 arms), sponsored by Department of Pharmaceutical Technology and Biopharmacy. Primary endpoint: Time until maximum effect on motor function. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON22984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22984.